Gatifloxacinacid manufacturers
|
| | Gatifloxacinacid Basic information |
| Product Name: | Gatifloxacinacid | | Synonyms: | Gatifloxacinacid;3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-(3-Methyl-1-piperazinyl)-4-oxo-, Monohydrochloride (9CI);3-Quinolinecarboxylicacid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-(3-Methyl-1-piperazinyl)-4-oxo-,hydrochloride (1:1);BMS 206584-01 hydrochloride;Gatifloxacin hydrochloride
(AM 1155 hydrochloride;PD 135432 hydrochloride);AM 1155 hydrochloride;AM 1155 HYDROCHLORIDE;BMS 206584-01 HYDROCHLORIDE;PD 135432 HYDROCHLORIDE | | CAS: | 121577-32-0 | | MF: | C19H22FN3O4.ClH | | MW: | 411.859 | | EINECS: | | | Product Categories: | | | Mol File: | 121577-32-0.mol |  |
| | Gatifloxacinacid Chemical Properties |
| storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | Soluble in DMSO | | form | Powder | | color | White to off-white |
| | Gatifloxacinacid Usage And Synthesis |
| Biological Activity | Gatifloxacin hydrochloride (AM-1155 hydrochloride) is a potent fluoroquinolone antibiotic with broad-spectrum antimicrobial activity. | | in vivo | Gatifloxacin hydrochloride (subcutaneous injection; 100 mg/kg; 3 times a day; 30 days) significantly decreases the number of lesions in mouse footpad with Nocardia brasiliensis . < p> | Animal Model: | Female BALB/c mice with Nocardia brasiliensis in the right hind footpad | | Dosage: | 100 mg/kg | | Administration: | Subcutaneous injection; 3 times a day; 30 days | | Result: | Reduced the production of lesions in mice. | | | target | | Topoisomerase II 36.7 μM () | |
| | Gatifloxacinacid Preparation Products And Raw materials |
|